The initial public offer (IPO) of Anondita Medicare received bids for 1,05,99,000 shares as against 34,43,000 shares on offer, as per NSE data as of 17:00 hours on Friday (22 August 2025). The issue was subscribed 3.07 times.
The issue opened for bidding on Friday (22 August 2025) and it will close on Tuesday (26 August 2025). The price of the IPO is fixed between Rs 137 – Rs 145 per share . The minimum order quantity is 1,000 equity shares. The equity shares will list on NSE’s SME platform.
The IPO comprises fresh issue of 47,93,000 shares. The promoter shareholding in the company will dilute to 61.71% post- IPO from 83.95% pre-IPO.
About 2,70,000 equity shares will be reserved for subscription by market maker to the issue. The net issue comprises of 45,23,000 equity shares. The issue and the net issue will constitute 26.50% and 25.01% respectively of the post issue paid up equity share capital of the company.
The company intends to utilize the net proceeds for capital expenditure, working capital requirements and general corporate purposes.
Anondita Medicare is a manufacturer of male condoms with a variety of flavors, with its flagship product marketed and sold under the brand “COBRA”. The company has installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated June 04, 2025. As on 31 July 2025, the company had 280 employees.
Ahead of the IPO, Anondita Medicare on Thursday, 21 August 2025, raised Rs 19.57 crore from anchor investors. The board allotted 13.50 lakh shares at Rs 145 each to 5 anchor investors.
The company recorded revenue from operations of Rs 76.99 crore and net profit of Rs 16.41 crore for the period ended 31 March 2025.